허혈성 신경세포손상이 아밀로이드 전구단백질의 대사에 미치는 영향
Effect of Ischemic Neuronal Insults on Amyloid Precursor Protein Processing
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: In spite of the different pathogenesis and exclusive respect in the diagnosis of Alzheimer's disease (AD) and vascular dementia (VaD), recent epidemiological and pathological studies indicates that ischemic stroke have an important role in the pathogenesis of both VaD and AD. However,the association of ischemic stroke and AD on the cellular and molecular level is still unknown. We evaluated the effect of ischemic neuronal insult on the regulation of amyloid precursor protein (APP) processing. Methods: We used an in vitro model of cerebral ischemia (oxygen-glucose deprivation, OGD) to evaluate the effect of ischemic insult on the amyloidogenic and non-amyloidogenic pathways using human neuroblastoma cell line, SH-SY5Y, and primary cultured cells of Tg2576 APP transgenic mouse. Results: Ischemic insult significantly increased the beta amyloid (Aβ) production in the primary cultured cells of Tg2576 APP transgenic mice (p<0.001). A disintegrin and metalloprotease 10 (ADAM 10), a candidate of α- secretase, was markedly increased in the early stage of ischemic insult (up to 2 hours of OGD, p<0.001; 4 hours of OGD, p<0.05), which was followed by the decreased level of ADAM 10 expression in a later stage (p<0.001). However, the protein and mRNA expression of β-site cleavage enzyme (BACE) and BACE activity were not significantly different between the group of ischemic insult and control. By contrast, the activity of γ-secretase was significantly increased after 4 hours of ischemic insult, as compared to controls. Conclusions: This study demonstrates that the ischemic neuronal insults increase the production of Aβ via activation of the amyloidogenic pathway, which may link the role of ischemic insults to the pathogenesis of AD.
참고문헌 (45)
- "Diagnostic and Statistical Manual of Mental Disorders", pp.138~142 (1994)
- "Alzheimer disease as a vascular disorder:nosological evidence", 33, pp.1152~1162 (2002)
- "Midlife blood pressure and dementia: the Honolulu-Asia Aging Study.", pp.49~55 (2000), Midlife blood pressure and dementia
- "and brain weight at death", pp.57~62 (2000), Midlife blood pressure and neuritic plaques
- "Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe(Syst-Eur)trial", 352, pp.1347~1351 (1998)
- "Atrial fibrillation and dementia in a population-based study.The Rotterdam Study", 28, pp.316~321 (1997)
- "Diabetes mellitus and the risk of dementia:the Rotterdam Study", 53, pp.1937~1942 (1999)
- "Vascular risk factors for Alzheimer's disease:an epidemiologic perspective", 21, pp.153~160 (2000)
- "Vascular factors in dementia", 13 suppl 3, pp.106~114 (1999)
- "Overlap between pathology of Alzheimer disease and vascular dementia", 13 suppl 3, pp.115~123 (1999)
- "Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease", 148, pp.2083~2095 (1996)
- "Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease", 354, pp.919~920 (1999)
- "Brain infarction and the clinical expression of Alzheimer disease.The Nun Study", 277, pp.813~817 (1997)
- "The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease", 8, pp.447~453 (1998)
- "Translating cell biology into therapeutic advances in Alzheimer's disease", 399, pp.~31 (1999)
- "The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor", 325, pp.733~736 (1987)
- "Regulation of APP cleavage by alpha-", pp.6~10
- "Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion", 21, pp.207~214 (2000)
- "Effect of propentofylline on hippocampal brain energy state and amyloid precursor protein concentration in a rat model of cerebral hypoperfusion", 105, pp.1065~1077 (1998)
- "Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion", 143, pp.287~295 (2001)
- "Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model", 853, pp.1~4 (2000)
- "Progressive parenchymal deposition of beta-amyloid protein in rat brain following global cerebral ischemia", 97, pp.359~368 (1999)
- "Partial purification and characterization of gamma-secretase from post-mortem human brain", 278, pp.24277~24284 (2003)
- "Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease", 96, pp.3922~3927 (1999)
- "Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor", 273, pp.27765~27767 (1998)
- "Putative function of ADAM9,ADAM10,and ADAM17 as APP alpha-secretase", 301, pp.231~235 (2003)
- "Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging,Alzheimer disease and Down syndrome", 32, pp.153~160 (2003)
- "Up-regulation of TNF-alpha convertase(TACE", ADAM17)after oxygen-glucose deprivation in rat forebrain slices, 2001, pp.40, 1094~1102
- "TACE", ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate, 2002, pp.22, 576~585
- "Upregulation of TACE", ADAM17 after ischemic preconditioning is involved in brain tolerance, 2002, pp.22, 1297~1302
- "Purification and cloning of amyloid precursor protein beta-secretase from human brain", pp.537~540
- "Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE", 286, pp.735~741 (1999)
- "Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease", 59, pp.1381~1389 (2002)
- "Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease", 51, pp.783~786 (2002)
- "Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus", 13, pp.2031~2033 (2002)
- "Beta-secretase(BACE)and GSK-3 mRNA levels in Alzheimer's disease", 116, pp.155~158 (2003)
- "Oxidative stress increases expression and activity of BACE in NT2 neurons", 10, pp.279~288 (2002)
- "Deficiency of presenillin-1 inhibits the normal cleavage of amyloid precursor protein", 391, pp.387~390 (1998)
- "Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice", 3, pp.67~72 (1997)
- "Protein topology of presenilin 1", 17, pp.1023~1030 (1996)
- "Evidence for a six- transmembrane domain structure of presenilin 1", 272, pp.12047~12051 (1997)
- "expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis", pp.~2 57 (2001)
- "Induction of presenilins in the rat brain after middle cerebral arterial occlusion", 48, pp.539~543 (1999)
- "Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1 beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells", 277, pp.30359~30367 (2002)
- "Presenilins in the heart:presenilin-2 expression is increased by low glucose and by hypoxia in cardiac cells", 110, pp.1~7 (2002)
